First Commonwealth Financial Corporation (FCF) furnished a current report announcing that it issued a press release with financial results for the three and nine months ended September 30, 2025. The company also declared a cash dividend of $0.135 per share on its common stock. The earnings information and dividend declaration are contained in the press release referenced in the filing.
Lee E. Lyon II filed an Initial Statement of Beneficial Ownership (Form 3) disclosing direct ownership of 92,739 shares of First Commonwealth Financial Corp (ticker FCF). The filing lists Mr. Lyon as an Executive Vice President and Chief Audit Executive, and indicates the reportable event date was 10/01/2025. The form was signed via power of attorney on 10/09/2025. No derivative securities or additional changes were reported.
James R. Reske, EVP and Chief Financial Officer of First Commonwealth Financial Corp. (FCF), reported a series of open-market sales on 10/06/2025 executed under a trading plan adopted 3/20/2025. The filings list multiple small sales that sum to 2,190 shares sold at prices ranging from $16.86 to $17.08, leaving reported direct beneficial ownership at 85,866 shares after the transactions. The filing also discloses outstanding service-based restricted stock units convertible 1-for-1 totaling 22,300 shares (7,000 from 2023, 8,000 from 2024, and 7,300 from 2025) that vest after their respective three-year service periods.
James R. Reske, EVP and Chief Financial Officer of First Commonwealth Financial Corp (FCF), reported multiple open-market sales totaling 2,190 shares of FCF common stock on 09/08/2025 at prices between $17.67 and $17.82 per share under a trading plan adopted March 20, 2025 to satisfy Rule 10b5-1 affirmative defense conditions. After these transactions, Mr. Reske directly beneficially owned 88,056 shares of common stock. The filing also discloses outstanding service-based restricted stock units awarded in 2023, 2024 and 2025 that convert 1-for-1 into common stock, totaling 22,300 RSUs outstanding.
Michael P. McCuen, EVP/Chief Banking Officer of First Commonwealth Financial Corp (FCF), reported a personal purchase of 2,826 shares of FCF common stock on 09/03/2025 at a price of $17.67 per share, resulting in 59,021 shares beneficially owned after the transaction. The reported holdings include 8,000 restricted shares vesting on 09/11/2026 and 30,000 restricted shares vesting in equal installments on 07/01/2026 and 07/01/2027. The filing also discloses service-based restricted stock unit awards: 6,800 from 2024 and 6,900 from 2025 (total 13,700), each converting 1-for-1 after three-year vesting periods. The Form 4 was signed by a POA on 09/04/2025.
Brian J. Sohocki, EVP/Chief Credit Officer and director of First Commonwealth Financial Corp (FCF) reported transactions on 08/18/2025. The filing shows 1,425 shares were disposed (code F) with $0 price, which the filer explains were shares withheld by the issuer to pay tax liability in connection with vesting. After the transaction, Mr. Sohocki beneficially owned 28,519 shares. The filing also discloses an award of 5,150 service-based restricted stock units granted in 2025 that convert 1-for-1 into common shares after a three-year vesting period. The form was submitted by a POA on behalf of Mr. Sohocki.
First Commonwealth Financial Corp filed a Form 13F reporting institutional holdings. The report lists 356 reported positions with a total market value of $463,094,848.
The filing also lists First Commonwealth Bank as an included manager; the report is signed by Teresa Ciambotti, SVP, Controller.
First Commonwealth Financial Corp. (FCF) – Form 144 filing: An undisclosed insider has notified intent to sell 39,774 common shares through broker Charles Schwab. At the filing’s reference price, the lot is valued at $659,453, representing roughly 0.04 % of the 104.9 million shares outstanding. The proposed sale window opens on 06 Aug 2025 on the NYSE.
The shares were obtained via equity-compensation grants issued between 2017-2024 under multiple Long-Term Incentive Plans: 20,720 shares (2018 grant), 9,001 (2017), 6,570 (2022) and 3,483 (2024). The filer reports no other sales in the prior three months. Standard Rule 144 and 10b5-1 representations are included, affirming no undisclosed material adverse information.
While insider sales can raise sentiment concerns, the transaction is modest in size relative to market float and appears to stem from normal incentive-plan vesting rather than a strategic divestiture.